|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online October 24, 2007
doi: 10.1242/10.1242/jcs.017301
Short Report |


1 Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Monteroni, 73100 Lecce, Italy
2 Department of Biochemistry, Institute for Cancer Research, the Norwegian Radium Hospital and Centre for Cancer Biomedicine, University of Oslo, Montebello, N-0310 Oslo, Norway
Authors for correspondence (e-mails: cecilia.bucci{at}unile.it; stenmark{at}ulrik.uio.no)
Accepted 22 August 2007
Summary
Lysosomal degradation of signalling receptors such as the epidermal growth factor (EGF) receptor (EGFR) is an important mechanism for termination of cell signalling. Such degradation involves the endosomal sorting of ubiquitylated receptors into intralumenal vesicles (ILVs) of multivesicular endosomes (MVEs) that move along microtubules to fuse with perinuclear lysosomes. The Rab7-interacting lysosomal protein RILP is interesting in this context as it interacts with Vps22 (also known as EAP30) and Vps36 (also known as EAP45), subunits of the endosomal sorting complex required for transport II (ESCRT-II), as well as with the dynein-dynactin motor complex. Because previous functional studies of RILP have been based on its overexpression, we have asked here whether RILP is required for endocytic trafficking of receptors. Depletion of RILP caused elevated levels of four late-endosomal molecules, lyso-bisphosphatidic acid, Lamp1, CD63 and cation-independent mannose-6-phosphate receptors. Electron microscopy showed that endosomes of RILP-depleted cells were morphologically distinct from normal late endosomes and had a strongly reduced content of ILVs. As in Vps22-depleted cells, ligand-mediated degradation of EGFRs was strongly inhibited in RILP-depleted cells, in which endocytosed EGFRs were found to accumulate in early endosomes. By contrast, endocytosis and recycling of transferrin receptors occurred normally in RILP-depleted cells. These results establish that RILP, like the ESCRT proteins, is required for biogenesis of MVEs and degradative trafficking of EGFRs but not for trafficking of transferrin receptors through early endosomes. We propose that RILP might coordinate the biogenesis of MVEs with dynein-mediated motility.
Key words: Dynein, Endosome, Lysosome, Membrane traffic, Rab7
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
P. A. Vanlandingham and B. P. Ceresa Rab7 Regulates Late Endocytic Trafficking Downstream of Multivesicular Body Biogenesis and Cargo Sequestration J. Biol. Chem., May 1, 2009; 284(18): 12110 - 12124. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mohammad-Panah, L. Wellhauser, B. E. Steinberg, Y. Wang, L. J. Huan, X.-D. Liu, and C. E. Bear An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice J. Cell Sci., April 15, 2009; 122(8): 1229 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Johannsdottir, R. Mancini, J. Kartenbeck, L. Amato, and A. Helenius Host Cell Factors and Functions Involved in Vesicular Stomatitis Virus Entry J. Virol., January 1, 2009; 83(1): 440 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Goebeler, M. Poeter, D. Zeuschner, V. Gerke, and U. Rescher Annexin A8 Regulates Late Endosome Organization and Function Mol. Biol. Cell, December 1, 2008; 19(12): 5267 - 5278. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leonard, A. Hayakawa, D. Lawe, D. Lambright, K. D. Bellve, C. Standley, L. M. Lifshitz, K. E. Fogarty, and S. Corvera Sorting of EGF and transferrin at the plasma membrane and by cargo-specific signaling to EEA1-enriched endosomes J. Cell Sci., October 15, 2008; 121(20): 3445 - 3458. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Spinosa, C. Progida, A. De Luca, A. M. R. Colucci, P. Alifano, and C. Bucci Functional Characterization of Rab7 Mutant Proteins Associated with Charcot-Marie-Tooth Type 2B Disease J. Neurosci., February 13, 2008; 28(7): 1640 - 1648. [Abstract] [Full Text] [PDF] |
||||